P
Patrycja Nowak-Sliwinska
Researcher at University of Geneva
Publications - 113
Citations - 5155
Patrycja Nowak-Sliwinska is an academic researcher from University of Geneva. The author has contributed to research in topics: Angiogenesis & Sunitinib. The author has an hindex of 34, co-authored 105 publications receiving 3949 citations. Previous affiliations of Patrycja Nowak-Sliwinska include École Polytechnique Fédérale de Lausanne & University Hospital of Lausanne.
Papers
More filters
Journal ArticleDOI
Consensus guidelines for the use and interpretation of angiogenesis assays
Patrycja Nowak-Sliwinska,Kari Alitalo,Elizabeth Allen,Andrey Anisimov,Alfred C. Aplin,Robert Auerbach,Hellmut G. Augustin,Hellmut G. Augustin,David O. Bates,Judy R. van Beijnum,R. Hugh F. Bender,Gabriele Bergers,Gabriele Bergers,Andreas Bikfalvi,Joyce Bischoff,Barbara C. Böck,Barbara C. Böck,Peter C. Brooks,Federico Bussolino,Bertan Cakir,Peter Carmeliet,Daniel Castranova,Anca Maria Cimpean,Ondine Cleaver,George Coukos,George E. Davis,Michele De Palma,Anna Dimberg,Ruud P.M. Dings,Valentin Djonov,Andrew C. Dudley,Neil Dufton,Sarah-Maria Fendt,Napoleone Ferrara,Marcus Fruttiger,Dai Fukumura,Bart Ghesquière,Bart Ghesquière,Yan Gong,Robert J. Griffin,Adrian L. Harris,Christopher C.W. Hughes,Nan W. Hultgren,M. Luisa Iruela-Arispe,Melita Irving,Rakesh K. Jain,Raghu Kalluri,Joanna Kalucka,Robert S. Kerbel,Jan Kitajewski,Ingeborg Klaassen,Hynda K. Kleinmann,Pieter Koolwijk,Elisabeth Kuczynski,Brenda R. Kwak,Koen Marien,Juan M. Melero-Martin,Lance L. Munn,Roberto F. Nicosia,Agnès Noël,Jussi Nurro,Anna-Karin Olsson,Tatiana V. Petrova,Kristian Pietras,Roberto Pili,Jeffrey W. Pollard,Mark J. Post,Paul H.A. Quax,Gabriel A. Rabinovich,Marius Raica,Anna M. Randi,Domenico Ribatti,Curzio Rüegg,Reinier O. Schlingemann,Reinier O. Schlingemann,Stefan Schulte-Merker,Lois E.H. Smith,Jonathan W. Song,Steven A. Stacker,Jimmy Stalin,Amber N. Stratman,Maureen Van de Velde,Victor W.M. van Hinsbergh,Peter B. Vermeulen,Johannes Waltenberger,Brant M. Weinstein,Hong Xin,Bahar Yetkin-Arik,Seppo Ylä-Herttuala,Mervin C. Yoder,Arjan W. Griffioen +90 more
TL;DR: In vivo, ex vivo, and in vitro bioassays that are available for the evaluation of angiogenesis are described and critical aspects that are relevant for their execution and proper interpretation are highlighted.
Journal ArticleDOI
The chicken chorioallantoic membrane model in biology, medicine and bioengineering.
TL;DR: A detailed review of the use of the CAM to study vascular biology and response of blood vessels to a variety of agonists is provided and distinct cultivation protocols discussing their advantages and limitations are presented.
Journal ArticleDOI
In vitro and in vivo photocytotoxicity of boron dipyrromethene derivatives for photodynamic therapy.
Siang Hui Lim,Cliferson Thivierge,Patrycja Nowak-Sliwinska,Junyan Han,Hubert van den Bergh,Georges Wagnières,Kevin Burgess,Hong Boon Lee +7 more
TL;DR: Studies of compound 5 on HSC-2 cells showed almost exclusive localization to mitochondria, induction of G(2)/M-phase cell cycle block, and onset of apoptosis, suggesting Iodinated BODIPY structures may have potential as new photodynamic therapy agents for cancer.
Journal ArticleDOI
Organometallic Ruthenium(II) Arene Compounds with Antiangiogenic Activity
Patrycja Nowak-Sliwinska,Patrycja Nowak-Sliwinska,Judy R. van Beijnum,Angela Casini,Alexey A. Nazarov,Georges Wagnières,Hubert van den Bergh,Paul J. Dyson,Arjan W. Griffioen +8 more
TL;DR: The reported ruthenium complexes show promising antimetastatic activity involving inhibition of angiogenesis and therefore are attractive agents for development of anticancer therapies based on combination of chemo- and angiostatic treatments.
Journal ArticleDOI
In vivo anti-tumor activity of the organometallic ruthenium(II)-arene complex [Ru(eta(6)-p-cymene)-Cl-2(pta)] (RAPTA-C) in human ovarian and colorectal carcinomas
Andrea Weiss,Andrea Weiss,Robert H. Berndsen,Maxime Dubois,Cristina Müller,Roger Schibli,Arjan W. Griffioen,Paul J. Dyson,Patrycja Nowak-Sliwinska +8 more
TL;DR: It is shown that the prototype compound, [Ru(η6-p-cymene)Cl2(pta)], where pta = 1,3,5-triaza-7-phosphaadamantane (RAPTA-C), reduces the growth of primary tumors in preclinical models for ovarian and colorectal carcinomas.